Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
SHMT2 encodes the mitochondrial form of a pyridoxal phosphate-dependent enzyme that catalyzes the reversible reaction of serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate. Zusätzlich bieten wir Ihnen SHMT2 Antikörper (37) und und viele weitere Produktgruppen zu diesem Protein an.
Showing 8 out of 9 products:
Findings support the hypothesis that age-associated respiration defects in fibroblasts of elderly humans are caused not by mtDNA mutations but by epigenetic regulation of nuclear genes including SHMT2.
SHMT2 Desuccinylation is associated with Cancer Cell Proliferation.
The one-carbon donor formate generally rescues cells from SHMT inhibition, but paradoxically increases the inhibitor's cytotoxicity in diffuse large B-cell lymphoma (DLBCL); this effect is rooted in defective glycine uptake in DLBCL cell lines, rendering them uniquely dependent upon SHMT enzymatic activity to meet glycine demand.
Our data confirm the heterogeneity of breast tumors at a functional proteomic level and dissects the relationship between metabolism-related proteins, pathological features and patient survival. These observations highlight the importance of SHMT2 and ASCT2 as valuable individual prognostic markers and potential targets for personalized breast cancer therapy
Data suggest that serine hydroxymethyltransferase 2 (SHMT2) may be a potential target in the treatment of hepatocellular carcinoma (HCC).
High SHMT2 expression is associated with idiopathic pulmonary fibrosis.
Site-directed mutagenesis experiments on SHMT1 demonstrate that selective enzyme inhibition relies on the presence of a cysteine residue at the active site of SHMT1 (Cys204) that is absent in SHMT2.
These results indicate that SHMT2 may be a valuable prognostic biomarker in ER-negative breast cancer cases
our results for the first time showed that miR-615-5p prevents proliferation and migration through negatively regulating SHMT2 in HCC.
The SHMT-2 is the direct targets of miR-370 and miR-373, respectively, in human articular chondrocytes.
High SHMT2 expression increases glycine-dependent nucleotide synthesis leading to bladder cancer growth.
SHMT2 is required for glioblastoma multiforme cells to adapt to the tumour environment, but also renders these cells sensitive to glycine cleavage system inhibition
SHMT1 exists in solution as a tetramer, both in the absence and presence of PLP, while SHMT2 undergoes a dimer-to-tetramer transition.
The present study not only describes individual genetic variation that directly affects SHMT1 and SHMT2 activity, but provided insight into the overall regulation of the Folate and Methionine Cycles.
SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis
This paper compares the mitochondrial and cytoplasmic forms of this enzyme and suggests that the two genes are a result of a single gene duplication.
This gene encodes the mitochondrial form of a pyridoxal phosphate-dependent enzyme that catalyzes the reversible reaction of serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate. The encoded product is primarily responsible for glycine synthesis. The activity of the encoded protein has been suggested to be the primary source of intracellular glycine. The gene which encodes the cytosolic form of this enzyme is located on chromosome 17. Alternative splicing results in multiple transcript variants.
, glycine auxotroph A, human complement for hamster
, glycine hydroxymethyltransferase
, serine aldolase
, serine hydroxymethylase
, serine hydroxymethyltransferase, mitochondrial
, serine methylase
, threonine aldolase
, serine hydroxymethyltransferase 2 (mitochondrial)
, mitochondrial serine hydroxymethyltransferase
, Glycine hydroxymethyltransferase
, Serine methylase